MXPA02012404A - Recuperacion del virus de moquillo canino del acido desoxirribonucleico complementario. - Google Patents

Recuperacion del virus de moquillo canino del acido desoxirribonucleico complementario.

Info

Publication number
MXPA02012404A
MXPA02012404A MXPA02012404A MXPA02012404A MXPA02012404A MX PA02012404 A MXPA02012404 A MX PA02012404A MX PA02012404 A MXPA02012404 A MX PA02012404A MX PA02012404 A MXPA02012404 A MX PA02012404A MX PA02012404 A MXPA02012404 A MX PA02012404A
Authority
MX
Mexico
Prior art keywords
canine distemper
distemper virus
rescue
cdna
viruses
Prior art date
Application number
MXPA02012404A
Other languages
English (en)
Spanish (es)
Inventor
Christopher L Parks
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of MXPA02012404A publication Critical patent/MXPA02012404A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MXPA02012404A 2000-06-23 2001-06-22 Recuperacion del virus de moquillo canino del acido desoxirribonucleico complementario. MXPA02012404A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21369800P 2000-06-23 2000-06-23
PCT/US2001/020157 WO2002000883A2 (en) 2000-06-23 2001-06-22 Rescue of canine distemper virus from cdna

Publications (1)

Publication Number Publication Date
MXPA02012404A true MXPA02012404A (es) 2003-04-25

Family

ID=22796152

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012404A MXPA02012404A (es) 2000-06-23 2001-06-22 Recuperacion del virus de moquillo canino del acido desoxirribonucleico complementario.

Country Status (11)

Country Link
US (1) US20050089985A1 (enExample)
EP (1) EP1303613A2 (enExample)
JP (1) JP2004501646A (enExample)
KR (2) KR20030013462A (enExample)
CN (1) CN1455816A (enExample)
AU (1) AU2001271423A1 (enExample)
BR (1) BR0112384A (enExample)
CA (1) CA2412621A1 (enExample)
IL (1) IL152930A0 (enExample)
MX (1) MXPA02012404A (enExample)
WO (1) WO2002000883A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003289858A (ja) * 2002-04-05 2003-10-14 Nippon Biologicals Inc イヌジステンパー及びリーシュマニア感染症に対する組換え体イヌジステンパーウイルスワクチン
CA2528002A1 (en) * 2003-06-09 2004-12-29 Wyeth Improved method for the recovery of non-segmented, negative-stranded rna viruses from cdna
CN101228272A (zh) * 2005-04-20 2008-07-23 生物载体株式会社 用于治疗阿尔茨海默病的具有较高安全性的经鼻腔内给药基因疫苗
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
NZ614571A (en) 2007-06-14 2014-12-24 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
US8227583B2 (en) 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
WO2010050586A1 (ja) * 2008-10-31 2010-05-06 ディナベック株式会社 組み換え蛋白質の発現を増強する方法
WO2010088552A1 (en) * 2009-01-30 2010-08-05 The Board Of Regents For Oklahoma State University Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
NZ599479A (en) † 2009-10-20 2013-11-29 Novartis Ag Improved reverse genetics methods for virus rescue
CN102329809B (zh) * 2010-07-12 2014-02-26 中国农业科学院哈尔滨兽医研究所 犬瘟热病毒cdv/r-20/8疫苗株的反向遗传操作系统及其应用
CN102586485B (zh) * 2012-03-12 2013-09-04 中国农业科学院哈尔滨兽医研究所 用于犬瘟热病毒野毒株与疫苗株鉴别诊断rt-lamp检测引物及其应用
KR101595445B1 (ko) 2013-12-31 2016-02-19 대한민국 수정진동자 바이오센서를 구비하는 개 디스템퍼 바이러스 검출 장치 및 이를 이용한 검출 방법
CN108138187B (zh) * 2015-08-10 2022-07-19 库瑞瓦格房地产有限公司 增加环状dna分子复制的方法
KR101940674B1 (ko) * 2017-05-19 2019-01-21 전북대학교 산학협력단 신경계 감염병 원인체를 검출하기 위한 조성물
EP3675903A1 (en) * 2017-09-23 2020-07-08 Boehringer Ingelheim Vetmedica GmbH Paramyxoviridae expression system
EP3852800A1 (en) * 2018-09-20 2021-07-28 Boehringer Ingelheim Vetmedica GmbH Intranasal vector vaccine against porcine epidemic diarrhea
CN109750006A (zh) * 2019-01-14 2019-05-14 青岛农业大学 一种犬瘟热病毒复制缺陷毒株及其构建方法
CN111733170A (zh) * 2020-07-01 2020-10-02 青岛农业大学 一种表达荧光素酶的重组犬麻疹病毒
CN113462656B (zh) * 2021-03-24 2022-09-30 兰州生物制品研究所有限责任公司 一种人三型副流感病毒冷适应温度敏感株及其应用
CN113416750A (zh) * 2021-07-05 2021-09-21 青岛农业大学 一种表达犬细小病毒2a型VP2的重组犬瘟热病毒
CN117653723B (zh) * 2023-12-01 2024-07-26 中山迈托姆生物技术有限公司 一种重组犬瘟热病毒疫苗的纯化方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155589A (en) * 1958-04-14 1964-11-03 Upjohn Co Parenteral extravascular injectable vaccines for simultaneous immunization of canidae against rabies, canine distemper, and infectious canine hepatitis
US3354038A (en) * 1964-12-02 1967-11-21 Affiliated Lab Corp Serial passaging tissue cultured canine distemper virus to form attenuated vaccine short of virus-antigenicity decreasing passages
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
JP2521226B2 (ja) * 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
DK0702085T4 (da) * 1994-07-18 2010-04-06 Conzelmann Karl Klaus Prof Dr Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus

Also Published As

Publication number Publication date
WO2002000883A2 (en) 2002-01-03
CN1455816A (zh) 2003-11-12
JP2004501646A (ja) 2004-01-22
AU2001271423A1 (en) 2002-01-08
CA2412621A1 (en) 2002-01-03
KR20090006239A (ko) 2009-01-14
IL152930A0 (en) 2003-06-24
KR20030013462A (ko) 2003-02-14
EP1303613A2 (en) 2003-04-23
BR0112384A (pt) 2003-09-23
US20050089985A1 (en) 2005-04-28
WO2002000883A3 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
MXPA02012404A (es) Recuperacion del virus de moquillo canino del acido desoxirribonucleico complementario.
WO2001009309A3 (en) RESCUE OF MUMPS VIRUS FROM cDNA
EA201201356A1 (ru) Композиция для лечения респираторных синцитиальных вирусов
WO2003092592A3 (en) Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
BR9915158A (pt) Método para preparação de citalopram
ATE257175T1 (de) Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
WO2005007805A3 (en) ANTISENSE ANTIVIRAL AGENT AND METHOD FOR TREATING ssRNA VIRAL INFECTION
ATE384126T1 (de) Interferon induzierende genetisch veränderte attenuierte viren
WO1999058659A3 (en) Methods and compositions for expression of transgenes in plants
WO2006033933A3 (en) Antisense antiviral compound and method for treating ssrna viral infection
WO2004113517A3 (en) IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA
WO2004041201A3 (en) Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
UA98620C2 (uk) Атенуйований вірус класичної лихоманки свиней, що містить модифікований глікопротеїн е2
WO2004000876A8 (en) INFECTIOUS cDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS
WO2005013905A3 (en) SENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION
Carpenter et al. In vivo restoration of biologically active 3'ends of virus-associated RNAs by nonhomologous RNA recombination and replacement of a terminal motif
MXPA01010320A (es) Produccion de vacunas con virus sincitial respiratorio quimerico atenuado a partir de secuencias nucleotidas clonadas.
WO1999051749A3 (en) Recombinant potyvirus construct and use thereof
WO2002000169A3 (en) Production of vaccines using transgenic plants
WO2001036614A3 (de) Das genom des hiv-1 intersubtyps (c/b') und seine anwendungen
CA2430115A1 (en) Recombinant rsv virus expression systems and vaccines
AU5460900A (en) Infectious cdna clone of gb virus b and uses thereof
WO2000043520A3 (en) Materials and methods for producing geminivirus resistant plants
Meyer et al. The complete nucleotide sequence of barley mild mosaic virus RNA1 and its relationship with other members of thePotyviridae
MX2025002276A (es) Un sars-cov-2 vivo atenuado y una vacuna preparada del mismo

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: EMERSON NETWORK POWER, ENERGY SYSTEMS, NORTH AMERI

FA Abandonment or withdrawal